Pharmacokinetic and Pharmacodynamic Obstacles for Phage Therapy From the Perspective of Clinical Practice
Clinical Infectious Diseases · 02.11.2023 · 77 (Supplement_5) · S395-S400
DOI: 10.1093/cid/ciad516 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 02.11.2023. Verfasst von Ryszard Międzybrodzki und 6 weiteren Autor:innen. Beteiligte Einrichtung: Bacteriophage Laboratory, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland. Hauptthemen laut MEDLINE: Phage Therapy, Bacterial Infections, Bacteriophages. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 65 Literaturangaben.
Abstract (Originalsprache)
Bacteriophages present unique features that enable targeted killing of bacteria, including strains resistant to many antibiotics. However, phage pharmacokinetics and pharmacodynamics constitute much more complex and challenging aspects for researchers than those attributable to antibiotics. This is because phages are not just chemical substances, but also biological nanostructures built of different proteins and genetic material that replicate within their bacterial hosts and may induce immune responses acting as simple antigens. Here, we present a few examples of how primary general assumptions on phage pharmacokinetics and pharmacodynamics are verified by current preclinical and clinical observations, leading to conclusions that may not be obvious at first but are of significant value for the final success of phage therapy in humans.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Bacteriophage Laboratory, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland.
- Phage Therapy Unit, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland.
- Department of Clinical Immunology, Medical University of Warsaw, Poland.
- Collegium Medicum, Jan Długosz University, Częstochowa, Poland.
- Clinic of Immunology, Transplantology and Internal Medicine, Infant Jesus Hospital, Medical University of Warsaw, Poland.
ORCID-Profile: Ryszard Międzybrodzki
Zitieren
APA
Międzybrodzki, R., Kasprzak, H., Letkiewicz, S., Rogóż, P., Żaczek, M., Thomas, J., & Górski, A. (2023). Pharmacokinetic and Pharmacodynamic Obstacles for Phage Therapy From the Perspective of Clinical Practice. Clinical Infectious Diseases, 77(Supplement_5), S395-S400. https://doi.org/10.1093/cid/ciad516
Vancouver
Międzybrodzki R, Kasprzak H, Letkiewicz S, Rogóż P, Żaczek M, Thomas J, et al. Pharmacokinetic and Pharmacodynamic Obstacles for Phage Therapy From the Perspective of Clinical Practice. Clinical Infectious Diseases. 2023;77(Supplement_5):S395-S400. doi:10.1093/cid/ciad516
BibTeX
@article{Midzybrodzki2023,
author = {Międzybrodzki, Ryszard and Kasprzak, Hubert and Letkiewicz, Sławomir and Rogóż, Paweł and Żaczek, Maciej and Thomas, Jamon and Górski, Andrzej},
title = {Pharmacokinetic and Pharmacodynamic Obstacles for Phage Therapy From the Perspective of Clinical Practice},
journal = {Clinical Infectious Diseases},
year = {2023},
volume = {77},
number = {Supplement_5},
pages = {S395--S400},
doi = {10.1093/cid/ciad516}
}
EUVIMED